-
- Posts: 6
- Joined: Mon Sep 06, 2004 6:24 pm
When we compare type and limit of related impürities in drug product
specifications , what types of differences should be mostly involved in origin drug product spesifications and generic drug product spesifications? I have no found enough information comperatively in ICH and FDA guidances.
Thank you for now.
